Literature DB >> 6705194

Changes in fatty acids in phospholipids of the bronchoalveolar fluid in bacterial pneumonia and in adult respiratory distress syndrome.

R P Baughman, E Stein, J MacGee, M Rashkin, H Sahebjami.   

Abstract

Fatty acids of the phospholipid fraction of bronchoalveolar lavage fluid from patients with bacterial pneumonia or with the adult respiratory distress syndrome were chromatographed and the patterns compared with those for a control group. In the control group, palmitic acid (16:0) was the predominant fatty acid, accounting for 58.0% (SD 8.25%) of the total fatty acid, a proportion significantly higher (p less than 0.001) than in the distress-syndrome group (42.1%, SD 4.88%) or the acute pneumonia group (32.1%, SD 1.73%). There was a greater proportion of oleic acid (18:1) in the disease groups; thus the ratio of palmitic to oleic acid was useful in distinguishing these three groups. No patient with a palmitic/oleic acid ratio greater than 2.45 had evidence of parenchymal inflammation. Of those with a ratio less than 1.3, 89% had acute bacterial pneumonia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6705194

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection.

Authors:  Matthew J Wargo; Maegan J Gross; Sathish Rajamani; Jenna L Allard; Lennart K A Lundblad; Gilman B Allen; Michael L Vasil; Laurie W Leclair; Deborah A Hogan
Journal:  Am J Respir Crit Care Med       Date:  2011-05-11       Impact factor: 21.405

Review 2.  The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections.

Authors:  SeungHye Han; Rama K Mallampalli
Journal:  Ann Am Thorac Soc       Date:  2015-05

3.  Fatty acid intake and the risk of community-acquired pneumonia in U.S. women.

Authors:  Michael Alperovich; Mark I Neuman; Walter C Willett; Gary C Curhan
Journal:  Nutrition       Date:  2007-01-22       Impact factor: 4.008

Review 4.  Changes in pulmonary surfactant during bacterial pneumonia.

Authors:  K A Brogden
Journal:  Antonie Van Leeuwenhoek       Date:  1991-05       Impact factor: 2.271

5.  Vitamin and micronutrient intake and the risk of community-acquired pneumonia in US women.

Authors:  Mark I Neuman; Walter C Willett; Gary C Curhan
Journal:  Am J Med       Date:  2007-04       Impact factor: 4.965

6.  Pathogenesis of oleic acid-induced lung injury in the rat: distribution of oleic acid during injury and early endothelial cell changes.

Authors:  G Beilman
Journal:  Lipids       Date:  1995-09       Impact factor: 1.880

7.  Fatty acid composition of lung, macrophage and surfactant phospholipids after short-term enteral feeding with n-3 lipids.

Authors:  J D Palombo; E E Lydon; P L Chen; B R Bistrian; R A Forse
Journal:  Lipids       Date:  1994-09       Impact factor: 1.880

8.  Decreased phosphatidylcholine in the lung fluid of patients with sarcoidosis.

Authors:  R P Baughman; S Strohofer; M Dohn
Journal:  Lipids       Date:  1985-07       Impact factor: 1.880

9.  Complexing of bacterial lipopolysaccharide with lung surfactant.

Authors:  K A Brogden; R C Cutlip; H D Lehmkuhl
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

10.  Recombinant human activated protein C ameliorates oleic acid-induced lung injury in awake sheep.

Authors:  Kristine Waerhaug; Mikhail Y Kirov; Vsevolod V Kuzkov; Vladimir N Kuklin; Lars J Bjertnaes
Journal:  Crit Care       Date:  2008-11-20       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.